EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline WEC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development BYRN Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Absence KUST Q4 2025 Earnings Deep EPS Miss Highlights Operational Challenges XCUR Q2 2022 Earnings EPS Miss Widens as PreRevenue Biotech Shares Edge Higher